Sabby Management’s PAVmed Inc. Series Z Warrant PAVMZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-436,973
Closed -$364K 156
2020
Q3
$364K Sell
436,973
-405,237
-48% -$386K 0.05% 89
2020
Q2
$867K Sell
842,210
-193,186
-19% -$213K 0.17% 50
2020
Q1
$962K Sell
1,035,396
-1,117,323
-52% -$891K 0.4% 25
2019
Q4
$836K Sell
2,152,719
-811,910
-27% -$255K 0.23% 21
2019
Q3
$949K Sell
2,964,629
-305,700
-9% -$104K 0.51% 23
2019
Q2
$1.37M Sell
3,270,329
-397,470
-11% -$159K 1.73% 13
2019
Q1
$1.43M Sell
3,667,799
-255,405
-7% -$90K 0.69% 18
2018
Q4
$1.25M Buy
3,923,204
+1,976,366
+102% +$663K 0.28% 32
2018
Q3
$915K Sell
1,946,838
-181,862
-9% -$90.3K 0.12% 57
2018
Q2
$704K Buy
+2,128,700
New +$1.05M 0.11% 72

Other funds holding PAVMZ

Sabby Management's PAVMZ Position: Q4 2020 in Review

Sabby Management sold out of PAVmed Inc. Series Z Warrant (PAVMZ) in Q4 2020, closing a stake of 436,973 shares — an estimated $364K sold.

Sabby Management first reported a position in PAVMZ in Q2 2018 and held it in 10 quarters. The position peaked at $1.43M in Q1 2019. 6 funds tracked by Wall St. Rank hold PAVMZ as of Q4 2020.

  • Sabby Management reported no remaining PAVmed Inc. Series Z Warrant position as of Q4 2020 after selling out during the quarter.
  • Sabby Management sold 436,973 PAVmed Inc. Series Z Warrant shares in Q4 2020, an estimated $364K.
  • Sabby Management first reported a position in PAVmed Inc. Series Z Warrant in Q2 2018 and held it in 10 quarters.
  • Sabby Management's PAVmed Inc. Series Z Warrant position peaked at $1.43M in Q1 2019.
  • 6 funds tracked by Wall St. Rank held PAVmed Inc. Series Z Warrant as of Q4 2020.

Based on Sabby Management's 13F filing for Q4 2020, filed 16 Feb 2021.